Toggle light / dark theme

Scientists grow novel ‘whole-brain’ organoid

Johns Hopkins University researchers have grown a novel whole-brain organoid, complete with neural tissues and rudimentary blood vessels—an advance that could usher in a new era of research into neuropsychiatric disorders such as autism.

“We’ve made the next generation of ,” said senior author Annie Kathuria, an assistant professor in JHU’s Department of Biomedical Engineering who studies and neuropsychiatric disorders. “Most brain organoids that you see in papers are one brain region, like the cortex or the hindbrain or midbrain. We’ve grown a rudimentary whole-brain organoid; we call it the multi-region brain organoid (MRBO).”

The research, published in Advanced Science, marks one of the first times scientists have been able to generate an organoid with tissues from each region of the brain connected and acting in concert. Having a human cell-based model of the brain will open possibilities for studying schizophrenia, autism, and other that affect the whole brain—work that typically is conducted in animal models.

Study finds cancer cells boost energy to survive mechanical stress and DNA damage

Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the journal Nature Communications. The surge of energy is the first reported instance of a defensive mechanism that helps cells repair DNA damage and survive the crowded environments of the human body.

The findings help explain how cancer cells survive complex mechanical gauntlets like crawling through a , sliding into porous blood vessels or enduring the battering of the bloodstream. The discovery of the mechanism can lead to new strategies that pin cancer cells down before they spread.

Researchers at the Center for Genomic Regulation (CRG) in Barcelona made the discovery using a specialized microscope that can compress living cells to just three microns wide, about one‑thirtieth the diameter of a human hair. They observed that within seconds of being squeezed, mitochondria in HeLA cells race to the surface of the nucleus and pump in extra ATP, the molecular energy source of cells.

Researchers make key gains in unlocking the promise of compact X-ray free-electron lasers

New research by scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab), in collaboration with scientists from TAU Systems Inc., has brought the promise of smaller and more affordable X-ray free-electron lasers one step closer to reality.

X-ray free-electron lasers (XFELs) are powerful light sources and are typically large research instruments. Scientists use them to probe nature’s secrets at the atomic level, enabling advances in medicine, biology, physics, materials, and more. The push to develop more compact and less expensive XFELs is expected to increase the number of facilities that will be able to implement this technology, greatly expanding its impact across many areas of science.

“As part of this effort, we are applying our long-standing expertise in a type of advanced accelerator called laser plasma acceleration to shrink XFELs,” said Sam Barber, a staff scientist in Berkeley Lab’s Accelerator Technology & Applied Physics (ATAP) Division. “In addition to standalone light sources, exceptionally high-quality electron beams from plasma accelerators could be injected into existing XFELs to significantly extend their performance.”

Human proteome study maps aging signatures across 13 organs

A multi-institutional team led by the Chinese Academy of Sciences has constructed a proteomic atlas of human aging across 13 organs, revealing tissue-specific aging clocks, transcriptome-proteome decoupling, and secreted proteins that may accelerate systemic decline.

Organ-specific aging and deterioration drive vulnerability to chronic diseases. Previous studies focused primarily on plasma proteins or DNA methylation profiles. No investigation has systematically mapped how protein quality control deteriorates differently across tissues identified organ‑specific biological age biomarkers.

In the study, “Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures,” published in Cell, researchers designed a multi-tissue , charting organ-level protein dynamics and aging-related biomarkers across five decades of adult life to construct a longitudinal proteomic atlas of human aging.

The relationship between lesion overlap with automatically segmented structures and treatment outcomes following MR-guided focused ultrasound thalamotomy for tremor

Optimal lesioning is essential for successful MR-guided focused ultrasound (MRgFUS) thalamotomies targeting the ventral intermediate nucleus (Vim) for tremors. This study aimed to evaluate the relationships between postoperative lesions that overlapped with the Vim and surrounding structures segmented automatically and the treatment outcomes.

This study included 48 patients who underwent MRgFUS thalamotomy targeting the Vim for essential tremors. The Clinical Rating Scale for Tremor (CRST) score was examined preoperatively as well as 1 week, 3 months, and 12 months postoperatively. Adverse effects were also assessed 1 month postoperatively. Using automatic segmentation software and fiber tracking software, the authors retrospectively segmented the Vim and surrounding structures, including the internal capsule (IC), ventrocaudal nucleus (Vc), zona incerta (ZI), and dentato-rubro-thalamic tract (DRTT), using preoperative images. Additionally, they manually delineated the coagulated lesions using images taken immediately after MRgFUS thalamotomy. The relationships between the volume and location of lesions overlapping with these structures, CRST improvement rates, and the presence of adverse effects were examined.

The mean thalamotomy volume was 0.076 ± 0.042 cm3 (median 0.085 cm3). The median improvement in the CRST score in the affected upper limb at 12 months postoperatively was 68.8%. Although no correlation was observed between lesion volume and CRST improvement at 1 week postoperatively, a positive correlation was observed between lesion volume and CRST improvement at 3 and 12 months. At 12 months, the authors observed a moderate correlation between the volume of the lesions overlapping with the Vim and improvement in the CRST score. A slightly stronger correlation was observed between the percentage of the lesion volume and the Vim. No correlation was found between lesion volume and improvements in the IC, Vc, ZI, DRTT, or CRST score. However, the authors found that both total lesion volume and the volume of lesion within the IC were significantly associated with gait imbalance.

/* */